Výsledky vyhledávání - "TAB Van Veen"

A polymorphism in Histidine-Rich Calcium Binding Protein as second hit in Phospholamban Cardiomyopathy

Autor: SM Van Der Voorn, K Dimitrova, E Van Drie, M Bourfiss, K Taha, R De Brouwer, TE Verstraelen, RA De Boer, FW Asselbergs, JP Van Tintelen, TAB Van Veen

Publikováno v: Cardiovascular research, 118(Suppl. 1):cvac066.134. Oxford University Press

Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): The Netherlands Cardio Vascular Research Initiative (CVON): the Dutch Heart Foundation, Dutch Federation of University Medical Center,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd3e6e47a069b5d331bcb437d78036f
https://pure.amc.nl/en/publications/a-polymorphism-in-histidinerich-calcium-binding-protein-as-second-hit-in-phospholamban-cardiomyopathy(a545d052-23fd-4966-9f34-17ae66a7d5fb).html

Zobrazit plný text záznamu

Buccal mucosa cells as a potential diagnostic tool to study onset and progression of arrhythmogenic cardiomyopathy

Autor: SM Van Der Voorn, HE Driessen, M Bourfiss, FHM Van Lint, F Mirzad, L El Onsri, MA Vos, TAB Van Veen

Publikováno v: Cardiovascular Research. 118

Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): The Netherlands Cardio Vascular Research Initiative (CVON) and 'Stichting Vriendenloterij' Background Arrhythmogenic cardiomyopathy (A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::644f4fe9fad64c1975e7bf9f517b0901
https://doi.org/10.1093/cvr/cvac066.121

Zobrazit plný text záznamu

Computational modeling identifies the cellular electromechanical effects of disrupted intracellular calcium handling in arrhythmogenic cardiomyopathy patients

Autor: A Lyon, WB Van Ham, SM Van Der Voorn, J Heijman, F Kirkels, A Vink, ASJM Te Riele, J Lumens, TAB Van Veen

Publikováno v: EP Europace. 24

Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): NWO - ZonMw (VIDI grant 016.176.340 to JL) Dutch Heart Foundation (ERA-CVD JTC2018 grant 2018T094; Dr. Dekker Program grant 2015T082 t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a843c11dc834cfe8ad953dabf956a6b
https://doi.org/10.1093/europace/euac053.593

Zobrazit plný text záznamu

Determining the role of uremic toxins on cardiac electrophysiology and pro-arrhythmia during chronic kidney disease

Autor: WB Van Ham, A Bossu, MJC Houtman, CM Cornelissen, MA Vos, TAB Van Veen

Publikováno v: EP Europace. 24

Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Young Talent Programme, CVON RECONNECT Introduction Chronic kidney disease (CKD) is represented by a diminished filtration capacity of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a10d1055b79f2dfed79293ffbbcd4b
https://doi.org/10.1093/europace/euac053.600

Zobrazit plný text záznamu

Fibrosis biomarkers as a predictive tool for clinical outcome in PLNR14Del patients

Autor: Mimount Bourfiss, Karim Taha, SM Van Der Voorn, M A Vos, Asjm Te Riele, Tab Van Veen

Publikováno v: EP Europace. 23

Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Netherlands Cardio Vascular Research Initiative (CVON): the Dutch heart foundation Background Mutations in phospholamban (PLN, most often PLNR14Del), a protein that

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::761a4a36a58be9a511af28e800b54e12
https://doi.org/10.1093/europace/euab116.034

Zobrazit plný text záznamu

Buccal mucosa cells as a diagnostic tool in patients with arrhythmogenic cardiomyopathy

Autor: SM Van Der Voorn, F Mirzad, M A Vos, H. E. Driessen, Fhm Van Lint, Mimount Bourfiss, Tab Van Veen, L El Onsri

Publikováno v: EP Europace. 23

Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Netherlands Cardio Vascular Research Initiative (CVON): the Dutch heart foundation Background Arrhythmogenic cardiomyopathy (ACM) is predominantly caused by mutatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70e9af4b1691ab153aacd0cae8e099cb
https://doi.org/10.1093/europace/euab116.035

Zobrazit plný text záznamu

Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes

Autor: M A Vos, Lukas Nalos, Marcel A.G. van der Heyden, Maaike Peschar, M. Houtman, R. van der Nagel, T.P. de Boer, Göran Duker, Martin B. Rook, Rosanne Varkevisser, Jet D.M. Beekman, Morten B. Thomsen, Peter Sartipy, Mkb Jonsson, Tab Van Veen

Publikováno v: British Journal of Pharmacology. 165:467-478

BACKGROUND AND PURPOSE Drug development requires the testing of new chemical entities for adverse effects. For cardiac safety screening, improved assays are urgently needed. Isolated adult cardiomyocytes (CM) and human embryonic stem cell-derived car

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29ec3594e46a5edc9cb8ab49e9cc5c56
https://doi.org/10.1111/j.1476-5381.2011.01558.x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání